Merck & Co., Inc.
MRK
$104.83
$0.200.19%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 64.24B | 63.62B | 63.92B | 64.17B | 63.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.24B | 63.62B | 63.92B | 64.17B | 63.17B |
| Cost of Revenue | 14.23B | 14.37B | 14.66B | 14.70B | 14.79B |
| Gross Profit | 50.01B | 49.25B | 49.27B | 49.47B | 48.39B |
| SG&A Expenses | 10.07B | 10.13B | 10.19B | 10.10B | 10.05B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.70B | 41.77B | 41.61B | 41.38B | 46.38B |
| Operating Income | 24.53B | 21.85B | 22.31B | 22.79B | 16.79B |
| Income Before Tax | 21.82B | 19.16B | 20.17B | 19.94B | 13.72B |
| Income Tax Expenses | 2.77B | 2.74B | 2.72B | 2.80B | 1.56B |
| Earnings from Continuing Operations | 19.04K | 16.42K | 17.45K | 17.13K | 12.16K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00M | -12.00M | -17.00M | -16.00M | -15.00M |
| Net Income | 19.03B | 16.41B | 17.43B | 17.12B | 12.15B |
| EBIT | 24.53B | 21.85B | 22.31B | 22.79B | 16.79B |
| EBITDA | 28.87B | 26.23B | 26.69B | 27.03B | 20.83B |
| EPS Basic | 7.57 | 6.50 | 6.89 | 6.75 | 4.79 |
| Normalized Basic EPS | 5.84 | 5.23 | 5.32 | 5.42 | 3.94 |
| EPS Diluted | 7.56 | 6.49 | 6.87 | 6.73 | 4.77 |
| Normalized Diluted EPS | 5.83 | 5.22 | 5.31 | 5.40 | 3.92 |
| Average Basic Shares Outstanding | 10.07B | 10.10B | 10.13B | 10.14B | 10.13B |
| Average Diluted Shares Outstanding | 10.08B | 10.12B | 10.15B | 10.17B | 10.16B |
| Dividend Per Share | 3.20 | 3.16 | 3.12 | 3.08 | 3.04 |
| Payout Ratio | 42.60% | 48.95% | 45.54% | 45.80% | 63.72% |